Winter in Tromsø
Through its central location in the Arctic city of Tromsø, Biotec Pharmacon and subsidiaries maintain a close relation to important academic institutions doing bio-prospecting in the Arctic area, like the University of Tromsø.
Biotec Pharmacon, the Company
Biotec Pharmacon ASA is a Norwegian public Company based in Tromsø north of the Arctic Circle.
The Group’s activities are focused in two operating subsidiaries:
- • Beta-Glucan applications in particular related to immune modulation
- • Marine Enzymes used in molecular biology.
Beta-Glucan applications
Biotec Pharmacon develops, manufactures and markets immune modulating compounds for the human health sectors. Basic research on the mode of action of the various proprietary beta-1,3/1,6-glucan products at a cellular/molecular level has been the foundation for scientific experiments in animal models and in clinical trials. Experience over a period of almost 20 years has confirmed that beta-1,3/1,6-glucan enhances overall disease resistance and improves health. Read more...
Marine Enzymes
The marine enzyme unit, organised in the subsidiary ArcticZymes AS, is focused on developing cold adapted enzymes for use in various RNA and DNA processes. All current products originates from fish or shrimps living in the cold seawaters in the Arctic Ocean off the coast of Norway and Svalbard. The preconditions for survival in these waters are “life systems” supporting life at very low temperatures.
Read more...
